1. Home
  2. RBCAA vs MNKD Comparison

RBCAA vs MNKD Comparison

Compare RBCAA & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RBCAA
  • MNKD
  • Stock Information
  • Founded
  • RBCAA 1974
  • MNKD 1991
  • Country
  • RBCAA United States
  • MNKD United States
  • Employees
  • RBCAA N/A
  • MNKD N/A
  • Industry
  • RBCAA Major Banks
  • MNKD Biotechnology: Pharmaceutical Preparations
  • Sector
  • RBCAA Finance
  • MNKD Health Care
  • Exchange
  • RBCAA Nasdaq
  • MNKD Nasdaq
  • Market Cap
  • RBCAA 1.3B
  • MNKD 1.2B
  • IPO Year
  • RBCAA 1998
  • MNKD 2004
  • Fundamental
  • Price
  • RBCAA $68.64
  • MNKD $3.99
  • Analyst Decision
  • RBCAA Hold
  • MNKD Buy
  • Analyst Count
  • RBCAA 1
  • MNKD 6
  • Target Price
  • RBCAA N/A
  • MNKD $9.33
  • AVG Volume (30 Days)
  • RBCAA 38.7K
  • MNKD 2.5M
  • Earning Date
  • RBCAA 07-18-2025
  • MNKD 08-11-2025
  • Dividend Yield
  • RBCAA 2.63%
  • MNKD N/A
  • EPS Growth
  • RBCAA 27.68
  • MNKD 228.27
  • EPS
  • RBCAA 6.28
  • MNKD 0.10
  • Revenue
  • RBCAA $369,212,000.00
  • MNKD $297,595,000.00
  • Revenue This Year
  • RBCAA $14.17
  • MNKD $13.62
  • Revenue Next Year
  • RBCAA $10.87
  • MNKD $15.18
  • P/E Ratio
  • RBCAA $10.90
  • MNKD $38.47
  • Revenue Growth
  • RBCAA 16.32
  • MNKD 32.50
  • 52 Week Low
  • RBCAA $54.88
  • MNKD $3.51
  • 52 Week High
  • RBCAA $80.68
  • MNKD $7.63
  • Technical
  • Relative Strength Index (RSI)
  • RBCAA 36.46
  • MNKD 53.73
  • Support Level
  • RBCAA $66.82
  • MNKD $3.70
  • Resistance Level
  • RBCAA $69.05
  • MNKD $4.13
  • Average True Range (ATR)
  • RBCAA 1.70
  • MNKD 0.16
  • MACD
  • RBCAA -0.76
  • MNKD 0.01
  • Stochastic Oscillator
  • RBCAA 16.37
  • MNKD 67.44

About RBCAA Republic Bancorp Inc.

Republic Bancorp Inc operates as a financial institution that provides both traditional and non-traditional banking products through five reportable segments. It has traditional banking which generates the majority of revenue, Warehouse Lending, Tax Refund Solutions (TRS), Republic Payment Solutions segment, and Republic Credit Solutions (RCS) business segments. The business activities of these segments include retail mortgage and commercial lending, construction and land development lending, internet lending, correspondent and indirect lending and also private banking, treasury management services, internet, and mobile banking, bank acquisitions, short-term revolving credit facilities, fixed-term residential real estate loans and receipt and payment of federal.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: